| Ticker Details |
|
Sana Biotechnology, Inc.
|
| IPO Date: |
February 1, 2021 |
| Sector: |
Healthcare |
| Industry: |
Biotech |
| Market Cap: |
$832.62M |
| Activated in VL: |
True |
| Average Daily Range |
| Avg Daily Range: |
$0.34 | 4.26%
|
| Avg Daily Range (30 D): |
$0.11 | 3.39%
|
| Avg Daily Range (90 D): |
$0.16 | 3.80%
|
| Institutional Daily Volume |
| Avg Daily Volume: |
1.9M |
| Avg Daily Volume (30 D): |
2.35M |
| Avg Daily Volume (90 D): |
2.72M |
| Trade Size |
| Avg Trade Size (Sh.): |
142 |
| Avg Trade Size (Sh.) (30 D): |
156 |
| Avg Trade Size (Sh.) (90 D): |
156 |
| Institutional Trades |
| Total Institutional Trades: |
1,495 |
| Avg Institutional Trade: |
$1.8M |
| Avg Institutional Trade (30 D): |
$1.37M |
| Avg Institutional Trade (90 D): |
$1.32M |
| Avg Institutional Trade Volume: |
.25M |
| Avg Institutional Trades (Per Day): |
1 |
| Market Closing Trades |
| Avg Closing Trade: |
$1.92M |
| Avg Closing Trade (30 D): |
$1.26M |
| Avg Closing Trade (90 D): |
$1.35M |
| Avg Closing Volume: |
272.71K |
|
|
| Financials |
| |
TTM |
Q4 2025 |
FY 2025 |
|
Basic EPS
|
$-.96
|
$-.21
|
$-.96
|
|
Diluted EPS
|
$-.96
|
$-.21
|
$-.96
|
|
Revenue
|
$M
|
$M
|
$M
|
|
Gross Profit
|
|
|
|
|
Net Income / Loss
|
$-244.17M
|
$-58.83M
|
$-244.17M
|
|
Operating Income / Loss
|
$-250.32M
|
$-61.2M
|
$-250.32M
|
|
Cost of Revenue
|
|
|
|
|
Net Cash Flow
|
$-55.33M
|
$-31.49M
|
$-55.33M
|
|
PE Ratio
|
|
|
|
|
|
|